2-[4-(oxolan-3-yl)phenyl]-4-(4-phenylphenyl)-6-[9-(4-phenylphenyl)dibenzofuran-3-yl]-1,3,5-triazine
C49H35N3O2 — CID 164798198
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[4-(oxolan-3-yl)phenyl]-4-(4-phenylphenyl)-6-[9-(4-phenylphenyl)dibenzofuran-3-yl]-1,3,5-triazine
2-[4-(oxolan-3-yl)phenyl]-4-(4-phenylphenyl)-6-[9-(4-phenylphenyl)dibenzofuran-3-yl]-1,3,5-triazine (PubChem CID 164798198) has the molecular formula C49H35N3O2 and a molecular weight of 697.84 g/mol. Its IUPAC name is 2-[4-(oxolan-3-yl)phenyl]-4-(4-phenylphenyl)-6-[9-(4-phenylphenyl)dibenzofuran-3-yl]-1,3,5-triazine.
Molecular Properties
| Compound Name | 2-[4-(oxolan-3-yl)phenyl]-4-(4-phenylphenyl)-6-[9-(4-phenylphenyl)dibenzofuran-3-yl]-1,3,5-triazine |
|---|---|
| PubChem CID | 164798198 |
| Molecular Formula | C49H35N3O2 |
| Molecular Weight | 697.84 g/mol |
| Exact Mass | 697.27 |
| IUPAC Name | 2-[4-(oxolan-3-yl)phenyl]-4-(4-phenylphenyl)-6-[9-(4-phenylphenyl)dibenzofuran-3-yl]-1,3,5-triazine |
| SMILES | c1ccc(-c2ccc(-c3nc(-c4ccc(C5CCOC5)cc4)nc(-c4ccc5c(c4)oc4cccc(-c6ccc(-c7ccccc7)cc6)c45)n3)cc2)cc1 |
| InChI | InChI=1S/C49H35N3O2/c1-3-8-32(9-4-1)34-14-20-37(21-15-34)42-12-7-13-44-46(42)43-27-26-40(30-45(43)54-44)49-51-47(38-22-16-35(17-23-38)33-10-5-2-6-11-33)50-48(52-49)39-24-18-36(19-25-39)41-28-29-53-31-41/h1-27,30,41H,28-29,31H2 |
| InChIKey | MPVQHJMNYYKMQE-UHFFFAOYSA-N |
| XLogP | 12.28 |
| TPSA | 61.04 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 54 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 697.84 |
| LogP ≤ 5 | 12.28 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 164798198 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.